Circulating cell‐free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV ‐positive Nigerian population
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70204 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Yinan Zheng und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, DNA Methylation, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally, with particularly high burdens among people living with HIV (PLWH) in low‐resource settings like Nigeria. Effective early detection remains a major challenge due to limited access to imaging‐based surveillance and the low sensitivity of current biomarkers such as alpha‐fetoprotein (AFP). We conducted an epigenome‐wide association study (EWAS) of circulating cell‐free DNA (ccfDNA) methylation in a Nigerian cohort of HIV‐positive individuals ( n = 245), spanning HCC, cirrhosis (FibroScan ≥12.3 kPa), fibrosis (FibroScan ≥7.6 and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Robert J. Havey MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- College of Health Sciences, University of Jos, Jos, Nigeria.
- College of Medicine, University of Lagos, Lagos, Nigeria.
- Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- School of Nursing, Yale University, West Haven, Connecticut, USA.
ORCID-Profile: Yinan Zheng, Hushan Yang
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Zheng, Y., Han, J., Qu, Y., Wang, J., Joyce, B. T., Okeke, E., Davwar, P. M., Duguru, M. J., Nyam, D. P., Odeghe, E., Oyeleke, G., Lesi, O. A., Imade, G. E., Sulaimon, A. A., Hawkins, C., Abdulkareem, F. B., Badmos, K., Gursel, D. B., Wei, J. J., …, & Hou, L. (2026). Circulating cell‐free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV ‐positive Nigerian population. International Journal of Cancer. https://doi.org/10.1002/ijc.70204
Vancouver
Zheng Y, Han J, Qu Y, Wang J, Joyce BT, Okeke E, et al. Circulating cell‐free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV ‐positive Nigerian population. International Journal of Cancer. 2026. doi:10.1002/ijc.70204
BibTeX
@article{Zheng2026,
author = {Zheng, Yinan and Han, Jingzhe and Qu, Yishu and Wang, Jun and Joyce, Brian T and Okeke, Edith and Davwar, Pantong M and Duguru, Mary J and Nyam, David P and Odeghe, Emuobor and Oyeleke, Ganiyat and Lesi, Olufunmilayo A and Imade, Godwin E and Sulaimon, Akanmu A and Hawkins, Claudia and Abdulkareem, Fatimah B and Badmos, Kabir and Gursel, Demirkan B and Wei, Jian-Jun and Silas, Olugbenga A and Kocherginsky, Masha and Kim, Kwang-Youn A and Sun, Zequn and Achenbach, Chad J and Zhang, Xuehong and Yang, Hushan and Sagay, Atiene S and Ogunsola, Folasade T and Murphy, Robert L and Roberts, Lewis R and Hou, Lifang},
title = {Circulating cell‐free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV ‐positive Nigerian population},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70204}
}
EUVIMED